Free Trial

Gemini Therapeutics (GMTX) News Today

Gemini Therapeutics logo
$56.91 -1.09 (-1.88%)
As of 07/11/2025

GMTX Latest News

Gemini Horoscope
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates GMTX, RMED, LOTZ
SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates BHVN, DRE, PLD, GMTX, SAFE
Gemini Therapeutics (Nasdaq:GMTX) Headline
Trading was temporarily halted for "GMTX" at 07:08 AM with a stated reason of "News pending."...
Gemini Therapeutics GAAP EPS of -$1.78 beats by $0.17
Gemini Therapeutics Reports 2021 Financial Results
Two more Cambridge biotechs cutting staff
Get Gemini Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for GMTX and its competitors with MarketBeat's FREE daily newsletter.

GMTX Media Mentions By Week

GMTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GMTX
News Sentiment

0.00

1.00

Average
Medical
News Sentiment

GMTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GMTX Articles
This Week

0

0

GMTX Articles
Average Week

Get Gemini Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for GMTX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:GMTX) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners